Hera Lai’s 10 year old child presented in casualty with snakebite since six hours. On examination no systemic signs are found and lab investigation are normal except localized swelling over the leg of < 5 cm. Which of the following is the next step in management?
**Core Concept**
The management of snakebite involves identifying patients at high risk of systemic envenoming and administering appropriate antivenom or supportive care. In this scenario, the child has no systemic signs and normal lab investigations, indicating a low risk of systemic envenoming.
**Why the Correct Answer is Right**
Given the absence of systemic signs and normal lab investigations, the child is classified as having a non-severe snakebite. The correct approach is to monitor the patient closely for any signs of systemic envenoming. The child does not require immediate antivenom administration, and the localized swelling is being managed conservatively.
**Why Each Wrong Option is Incorrect**
**Option A:** Administering antivenom in this scenario is not justified due to the lack of systemic signs and normal lab investigations. Antivenom is typically reserved for patients with systemic envenoming or severe local envenoming.
**Option B:** Monitoring for systemic signs is crucial, but the child has already been examined and found to have no systemic signs. This option does not address the immediate need for management.
**Option C:** There is no indication for surgical intervention in this scenario, as the child has localized swelling without signs of compartment syndrome or significant tissue damage.
**Option D:** This option is not relevant to the management of snakebite and is not a recommended approach.
**Clinical Pearl / High-Yield Fact**
Remember that the management of snakebite involves a tiered approach: identifying high-risk patients, administering antivenom or supportive care, and closely monitoring for systemic signs. Be cautious of patients with normal initial presentations who may develop systemic envenoming later.
**Correct Answer:** C.